Product Comparison


  Seqirus USA Inc 70461031803 Seqirus USA Inc 70461041810 Seqirus USA Inc 33332041810 Seqirus USA Inc 33332031801 Medimmune 66019030510
McKesson # 1087937 1087938 1087940 1087941 1088857
Description Flucelvax® Quadrivalent 2018 Flu Vaccine 60 mcg / 0.5 mL Indicated For People 4 Years of Age and Above Prefilled Syringe 0.5 mL Flucelvax® Quadrivalent 2018 Flu Vaccine 60 mcg / 0.5 mL Indicated For People 4 Years of Age and Above Multiple Dose Vial 5 mL Afluria® Quadrivalent 2018 Flu Vaccine 60 mcg / 0.5 mL Indicated for People 6 Months of Age and Above Multiple Dose Vial 5 mL Afluria® Quadrivalent 2018 Flu Vaccine 60 mcg / 0.5 mL Indicated For People 3 Years of Age and Above Prefilled Syringe 0.5 mL FluMist® Quadrivalent 2018 Flu Vaccine 10E6.5 - 7.5 FFU Indicated For People 2 to 49 Years of Age Intranasal Sprayer 0.2 mL
Manufacturer # 7046103180370461041810333320418103333203180166019030510
Brand Flucelvax® Quadrivalent 2018Flucelvax® Quadrivalent 2018Afluria® Quadrivalent 2018Afluria® Quadrivalent 2018FluMist® Quadrivalent 2018
Manufacturer Seqirus USA IncSeqirus USA IncSeqirus USA IncSeqirus USA IncMedimmune
Invoice FLUCELVAX 2018, QUAD SYR 0.5ML(10DOSE/BX)FLUCELVAX 2018, QUAD MDV 5ML (10DOSE/VL)AFLURIA 2018, QUAD MDV 5ML (10DOSE/VL)AFLURIA 2018, QUAD SYR 0.5ML (10DOSE/BX)FLUMIST QUAD 2018, SPR (10DOSE/BX)
    Log In to Order   Log In to Order   Log In to Order   Log In to Order   Log In to Order

Comparison

Container Type Prefilled SyringeMultiple Dose VialMultiple Dose VialPrefilled SyringeIntranasal Sprayer
Dosage Form InjectionInjectionInjectionInjectionSpray
NDC Number 7046103180370461041810333320418103333203180166019-0305-10
Strength 60 mcg / 0.5 mL60 mcg / 0.5 mL60 mcg / 0.5 mL60 mcg / 0.5 mL10E6.5 - 7.5 FFU
Type IntramuscularIntramuscularIntramuscularIntramuscularIntranasal
User Indicated For People 4 Years of Age and AboveIndicated For People 4 Years of Age and AboveIndicated For People 6 Months of Age and AboveIndicated For People 3 Years of Age and AboveIndicated For People 2 to 49 Years of Age
Volume 0.5 mL5 mL5 mL0.5 mL0.2 mL
Application Flu VaccineFlu VaccineFlu VaccineFlu VaccineFlu Vaccine
Storage Requirements Requires RefrigerationRequires RefrigerationRequires RefrigerationRequires RefrigerationRequires Refrigeration
UNSPSC Code 5120160851201608512016085120160851201608
Features and Benefits
  • FLUCELVAX QUADRIVALENT is an inactivated vaccine indicated for active immunization for the prevention of influenza disease caused by influenza virus subtypes A and type B contained in the vaccine
  • FLUCELVAX is approved for use in persons 4 years of age and older
  • FLUCELVAX QUADRIVALENT is standardized according to United States Public Health Service requirements for the 2017-2018 influenza season and is formulated to contain a total of 60 micrograms (mcg) hemagglutinin (HA) per 0.5 mL dose in the recommended ratio of 15 mcg HA of each of the following four influenza strains: A/Singapore/GP1908/2015 IVR-180 (H1N1) (an A/Michigan/45/2015-like virus); A/Singapore/GP2050/2015 (H3N2) (an A/Hong Kong/4801/2014 – like virus); B/Utah/9/2014 (a B/Phuket/3073/2013-like virus); B/Hong Kong/259/2010 (a B/Brisbane/60/08-like virus)
  • FLUCELVAX QUADRIVALENT 0.5 mL pre-filled syringes contain no preservative or antibiotics
  • FLUCELVAX QUADRIVALENT is an inactivated vaccine indicated for active immunization for the prevention of influenza disease caused by influenza virus subtypes A and type B contained in the vaccine
  • FLUCELVAX is approved for use in persons 4 years of age and older
  • FLUCELVAX QUADRIVALENT is standardized according to United States Public Health Service requirements for the 2017-2018 influenza season and is formulated to contain a total of 60 micrograms (mcg) hemagglutinin (HA) per 0.5 mL dose in the recommended ratio of 15 mcg HA of each of the following four influenza strains: A/Singapore/GP1908/2015 IVR-180 (H1N1) (an A/Michigan/45/2015-like virus); A/Singapore/GP2050/2015 (H3N2) (an A/Hong Kong/4801/2014 – like virus); B/Utah/9/2014 (a B/Phuket/3073/2013-like virus); B/Hong Kong/259/2010 (a B/Brisbane/60/08-like virus)
  • FLUCELVAX QUADRIVALENT 5 mL multi-dose vial formulation contains no antibiotics
  • AFLURIA QUADRIVALENT is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine
  • AFLURIA QUADRIVALENT is approved for use in persons 6 Months and older
  • AFLURIA QUADRIVALENT is standardized according to USPHS requirements for the 2017-2018 influenza season and is formulated to contain 60 mcg hemagglutinin (HA) per 0.5 mL dose in the recommended ratio of 15 mcg HA for each of the four influenza strains recommended for the 2017-2018 Northern Hemisphere influenza season: A/Singapore/GP1908/2015 (H1N1), IVR-180A, A/Hong Kong/4801/2014 (H3N2), NYMC X-263B, B/Phuket/3073/2013 BVR-1B and B/Brisbane/46/2015
  • The multi-dose presentation contains thimerosal added as a preservative; each 0.5 mL dose contains 24.5 mcg of mercury
  • AFLURIA QUADRIVALENT is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine
  • AFLURIA QUADRIVALENT is approved for use in persons 3 Years of age and older
  • AFLURIA QUADRIVALENT is standardized according to USPHS requirements for the 2017-2018 influenza season and is formulated to contain 60 mcg hemagglutinin (HA) per 0.5 mL dose in the recommended ratio of 15 mcg HA for each of the four influenza strains recommended for the 2017-2018 Northern Hemisphere influenza season: A/Singapore/GP1908/2015 (H1N1), IVR-180A, A/Hong Kong/4801/2014 (H3N2), NYMC X-263B, B/Phuket/3073/2013 BVR-1B and B/Brisbane/46/2015
  • FluMist®Quadrivalent (Influenza Vaccine Live, Intranasal) is a vaccine indicated for active immunization of persons 2-49 years of age for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine
  • FluMist®Quadrivalent is for intranasal administration only
  • FluMist Quadrivalent contains four vaccine virus strains: an A/H1N1 strain, an A/H3N2 strain and two B strains
  • FluMist Quadrivalent contains 4 influenza virus strains that are weakened (A(H1N1), A(H3N2), B Yamagata lineage, and B Victoria lineage)